Richard Lehman’s journal review—6 October 2014

NEJM 2 October 2014 Vol 371 1285  Here is a trial which had me taking my glasses off and scratching my bald patch. Why on earth should a drug company—in this case Boehringer Ingelheim— want to pay for a trial of taking patients OFF a drug? And why in particular should it want to take people […]

Read More…

Richard Smith: Improving health through the community in Tunisia

Tunisia, like all low and middle income countries, is having to respond to non-communicable disease after making good progress in reducing infectious disease and improving child and maternal health. Premature deaths from cardiovascular disease increased there by 35% between 1990 and 2010; they increased by 112% in Egypt and by 61% in Saudi Arabia—but fell by […]

Read More…

The BMJ Today: More on climate change

Earlier this year, The BMJ’s editor in chief, Fiona Godlee, was one of 50 senior UK medical professionals to sign a letter in the Times newspaper about the health benefits of ending investment in fossil fuels, and diverting funds instead to alternative energy and more active forms of transport. On 1 October 2014, The BMJ […]

Read More…

Suchita Shah: Malaria in the Little Novels of Sicily and why we need literature in medicine

“And you feel you could touch it with your hand—as if it smoked up from the fat earth, there, everywhere, round about the mountains that shut it in, from Agnone to Mount Etna capped with snow – stagnating in the plain like the sultry heat of June.” With these words Sicilian writer Giovanni Verga begins […]

Read More…